Canada markets closed

Syndax Pharmaceuticals Inc (1T3.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
18.600.00 (0.00%)
As of 08:19AM CEST. Market open.
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-240,634
-209,360
-149,338
24,926
-73,158
Depreciation & amortization
12
12
33
43
89
Stock based compensation
33,612
30,951
16,019
13,317
9,057
Change in working capital
15,873
31,860
1,656
-9,597
-7,934
Accounts Payable
752
5,611
-1,319
2,161
-2,670
Other working capital
-204,921
-160,601
-133,675
29,002
-71,260
Other non-cash items
873
739
1,524
187
816
Net cash provided by operating activites
-204,921
-160,601
-133,675
29,131
-71,260
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-129
-
Purchases of investments
-460,406
-354,606
-495,346
-294,719
-278,937
Sales/Maturities of investments
458,701
472,215
308,933
253,975
136,407
Net cash used for investing activites
-1,705
117,609
-186,188
-40,873
-142,530
Cash flows from financing activities
Debt repayment
-
0
-20,996
0
0
Common stock issued
-
258,094
181,390
86,337
278,060
Other financing activites
-
-
-
576
1
Net cash used privided by (used for) financing activities
263,826
264,132
172,254
118,464
304,424
Net change in cash
57,200
221,140
-147,609
106,722
90,634
Cash at beginning of period
57,632
74,471
222,080
115,358
24,724
Cash at end of period
114,832
295,611
74,471
222,080
115,358
Free Cash Flow
Operating Cash Flow
-204,921
-160,601
-133,675
29,131
-71,260
Capital Expenditure
-
-
-
-129
-
Free Cash Flow
-204,921
-160,601
-133,675
29,002
-71,260